Skip to main navigation
Enliven Therapeutics Logo
  • Home
  • About Us
    • Team
    • Board of Directors
    • Scientific Advisors
    • Investors
  • Approach
  • Pipeline
    • BCR-ABL Program
    • HER2 Program
    • Additional Programs
    • Program Presentations & Publications
  • Investors
    • News
      • Presentations
    • Events
    • Stock Information
      • Stock Quote & Chart
      • Historic Price Lookup
      • Analyst Coverage
    • Corporate Governance
      • Docs and Charters
      • Management
      • Board of Directors
    • Financials & Filings
      • SEC Filings
    • IR Resources
      • FAQs
      • Email Alerts
      • Contact Us
  • Careers
    • Values
    • Job Opportunities
  • Contact

Press Releases

Date Title View
May 31, 2023
Enliven Therapeutics to Present at Two Upcoming Investor Conferences
PDF Version
May 11, 2023
Enliven Therapeutics Highlights Business Achievements and Reports First Quarter 2023 Financial Results
PDF Version
February 23, 2023
Enliven Therapeutics Closes Merger with Imara and Private Placement of $165 Million
PDF Version

Print Page

Email Alerts

RSS Feeds

Contact Us

Investor Relations

  • News
    • Press Releases
    • Presentations
  • Events
  • Stock Information
    • Stock Quote & Chart
    • Historic Price Lookup
    • Analyst Coverage
  • Corporate Governance
    • Governance Documents
    • Management Team
    • Board of Directors
    • Scientific Advisors
  • Financials & Filings
    • SEC Filings
  • IR Resources
    • FAQs
    • Email Alerts
    • Contact Us
  • More
    • Home
    • About Us
      • Team
      • Board of Directors
      • Scientific Advisors
      • Investors
    • Approach
    • Pipeline
      • BCR-ABL Program
      • HER2 Program
      • Additional Programs
      • Program Presentations & Publications
    • Investors
      • News
        • Presentations
      • Events
      • Stock Information
        • Stock Quote & Chart
        • Historic Price Lookup
        • Analyst Coverage
      • Corporate Governance
        • Docs and Charters
        • Management
        • Board of Directors
      • Financials & Filings
        • SEC Filings
      • IR Resources
        • FAQs
        • Email Alerts
        • Contact Us
    • Careers
      • Values
      • Job Opportunities
    • Contact
    • Privacy Policy
    • Terms of Use
    Enliven Therapeutics Logo

    6200 Lookout Road
    Boulder, CO 80301

    General & Business Inquiries:
    info@enliventherapeutics.com

    Investor Inquiries:
    ir@enliventherapeutics.com

    Media Inquiries:
    media@enliventherapeutics.com

    Employment Inquiries:
    hr@enliventherapeutics.com

    LinkedIn

    • Privacy Policy
    • Terms of Use
    © 2023 Enliven Therapeutics All rights reserved.